Avicenna Alliance at IMDRF meeting in Berlin

Once again, it is a fantastic opportunity for the Avicenna Alliance to be invited by the IMDRF as an observer to network, listen and discuss the priorities of regulators and the importance of in silico methods and digital evidence. With Andromachi Kaltampani, Voisin Consulting Life Sciences (VCLS), our Secretary General Thierry Marchal had the opportunity to interact with regulators, policy makers, notified bodies, academic leaders and representatives of the regulatory affairs industry .

At Berlin 2023, we participated in exciting discussions on central conference themes including orphan diseases, pediatric devices, personalized devices and medical innovation: a huge opportunity for digital evidence that should be discussed more explicitly in the future IMDRF in 2024.